Project Details
Description
This is a multicenter prospective study to assess clinical characteristics, demographics, treatment and health-related quality of life (HRQoL) of lupus nephritis (LN) participants across 5 Gulf countries (United Arab Emirates [UAE], Qatar, Bahrain, Kuwait and Oman).
| Status | Finished |
|---|---|
| Effective start/end date | 14/09/21 → 30/01/23 |
Collaborative partners
- GlaxoSmithKline (lead)
- Dubai Health Authority
Keywords
- LUNELORD
- Systemic Lupus Erythematosus
- Lupus Nephritis
- Organ Damage
- Gulf Countries
- Real-world
- Connective Tissue Diseases
- Autoimmune Diseases
- Immune System Diseases
- Kidney Diseases
- Urologic Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Male Urogenital Diseases
- Glomerulonephritis
- Nephritis
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.